Michael Sela

29.0k total citations · 6 hit papers
526 papers, 23.0k citations indexed

About

Michael Sela is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Michael Sela has authored 526 papers receiving a total of 23.0k indexed citations (citations by other indexed papers that have themselves been cited), including 269 papers in Molecular Biology, 188 papers in Radiology, Nuclear Medicine and Imaging and 132 papers in Immunology. Recurrent topics in Michael Sela's work include Monoclonal and Polyclonal Antibodies Research (188 papers), Glycosylation and Glycoproteins Research (69 papers) and Protein purification and stability (59 papers). Michael Sela is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (188 papers), Glycosylation and Glycoproteins Research (69 papers) and Protein purification and stability (59 papers). Michael Sela collaborates with scholars based in Israel, United States and France. Michael Sela's co-authors include Ruth Arnon, Christian B. Anfinsen, Dvora Teitelbaum, Yosef Yarden, Edna Mozes, Rina Aharoni, Ephraim Katchalski, Esther Hurwitz, Ruth Arnon and Hugh O. McDevitt and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael Sela

518 papers receiving 20.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE KINETICS OF FORMATION OF NATIVE RIBONUCLEASE DURING OXIDATION OF THE REDUCED POLYPEPTIDE CHAIN

1961 797 citations Michael Sela et al. Proceedings of the National Academy of Sciences profile →
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

1996 645 citations Ronit Pinkas‐Kramarski, Lior Soussan et al. The EMBO Journal profile →
Some spectrophotometric and polarimetric experiments with ribonuclease

1957 268 citations Michael Sela et al. profile →
Reductive Cleavage of Disulfide Bridges in Ribonuclease

1957 213 citations Michael Sela et al. profile →
The correlation of ribonuclease activity with specific aspects of tertiary structure

1957 202 citations Michael Sela et al. profile →
The reductive cleavage of disulfide bonds and its application to problems of protein structure

1959 146 citations Michael Sela et al. profile →

Peers

Countries citing papers authored by Michael Sela

Since Specialization

Citations

This map shows the geographic impact of Michael Sela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sela more than expected).

Fields of papers citing papers by Michael Sela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sela. The network helps show where Michael Sela may publish in the future.

Co-authorship network of co-authors of Michael Sela

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sela. A scholar is included among the top collaborators of Michael Sela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sela. Michael Sela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis 2020 ·Journal of Neuroimmunology ·Rina Aharoni, Raya Eilam, Nofar Schottlender, Lihi Radomir, Sandra Leistner‐Segal, Tali Feferman, Dana Hirsch, Michael Sela, Ruth Arnon	12
2	Examination of HER3 targeting in cancer using monoclonal antibodies 2015 ·Proceedings of the National Academy of Sciences ·Nadège Gaborit, Ali Abdul‐Hai, Maicol Mancini, Moshit Lindzen, Sara Lavi, Orith Leitner, (unknown), (unknown), (unknown), (unknown), Christel Larbouret, Thierry Chardès, Hervé Bazin, André Pèlegrin, Michael Sela, Yosef Yarden	35
3	Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2 2013 ·Proceedings of the National Academy of Sciences ·Ruth Maron, Bilha Schechter, Maicol Mancini, (unknown), Yosef Yarden, Michael Sela	37
4	Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR 2013 ·Proceedings of the National Academy of Sciences ·Daniela A. Ferraro, Nadège Gaborit, Ruth Maron, Hadas Cohen‐Dvashi, Ziv Porat, Fresia Pareja, Sara Lavi, Moshit Lindzen, Nir Ben‐Chetrit, Michael Sela, Yosef Yarden	93
5	Immunomodulatory Vaccines Against Autoimmune Diseases 2006 ·Rejuvenation Research ·Michael Sela	15
6	Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone® 2001 ·Journal of Neuroimmunology ·Talma Brenner, Ruth Arnon, Michael Sela, Oded Abramsky, Zeev Meiner, (unknown), (unknown), Dvora Teitelbaum	106
7	c-Cbl Is a Suppressor of the Neu Oncogene 2000 ·Journal of Biological Chemistry ·Gil Levkowitz, Shlomo Oved, Leah N. Klapper, Daniel Harari, Sara Lavi, Michael Sela, Yosef Yarden	65
8	Multiple forms of the major phenylalanine specific protease in Treponema denticola 1999 ·Journal of Periodontal Research ·Graciela Rosen, Ronit Naor, Michael Sela	13
9	The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin 1998 ·Oncogene ·Ronit Pinkas‐Kramarski, Anne E.G. Lenferink, Sarah Bacus, Ljuba Lyass, (unknown), Leah N. Klapper, Eldad Tzahar, Michael Sela, (unknown), Yosef Yarden	75
10	Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. breakdown → 1996 ·The EMBO Journal ·Ronit Pinkas‐Kramarski, Lior Soussan, Hayley R. Waterman, Gil Levkowitz, Iris Alroy, Leah N. Klapper, Sara Lavi, Rony Seger, Barry Ratzkin, Michael Sela, Yosef Yarden	645
11	Synthetic Vaccines for Infectious and Autoimmune Diseases 1996 ·Advances in experimental medicine and biology ·Michael Sela	1
12	Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. 1995 ·Proceedings of the National Academy of Sciences ·Esther Hurwitz, Ilana Stancovski, Michael Sela, Yosef Yarden	132
13	Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. 1993 ·The Journal of Immunology ·Ilana Stancovski, Daniel Schindler, Tova Waks, Yosef Yarden, Michael Sela, Zelig Eshhar	169
14	The effect of leukocyte hydrolases on bacteria 1975 ·Inflammation ·Michael Sela, Meir Lahav, (unknown), (unknown), Isaac Ginsburg	35
15	Genetic control of immune response. The dose of antigen given in aqueous solution is critical in determining which mouse strain is high responder to poly(LTyr, LGlu)-poly(LPro)--poly(LLys). 1975 ·The Journal of Experimental Medicine ·(unknown), Edna Mozes, Michael Sela	13
16	Inverse relationship between net electric charge on the antigen and that on the sensitized cell in cellular immune response: demonstration with basic encephalitogen of the brain. 1975 ·The Journal of Experimental Medicine ·Dvora Teitelbaum, Cynthia Webb, (unknown), (unknown), Ruth Arnon, Michael Sela	8
17	THE GENETIC CONTROL OF ANTIBODY SPECIFICITY 1969 ·The Journal of Experimental Medicine ·Edna Mozes, Hugh O. McDevitt, Jean‐Claude Jaton, Michael Sela	87
18	Synthetic antigens composed exclusively of L- or D-amino acids. I. Effect of optical configuration on the immunogenicity of synthetic polypeptides in mice. 1967 ·PubMed Central ·Charles A. Janeway, Michael Sela	53
19	Cytolipin H‐Specific Antibodies Obtained with a Synthetic Polypeptide Conjugate 1967 ·European Journal of Biochemistry ·Ruth Arnon, Michael Sela, (unknown), David J. Shapiro	25
20	Immunological Studies with Synthetic Polypeptides 1966 ·Advances in immunology ·Michael Sela	152

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact